Substituted quinazoline compounds and methods of use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10144724
APP PUB NO 20170022184A1
SERIAL NO

15217304

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ARAXES PHARMA LLC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Feng, Jun San Diego, US 194 3765
Li, Liansheng San Diego, US 146 4977
Liu, Yi San Diego, US 765 9430
Liu, Yuan San Diego, US 280 2580
Long, Yun Oliver San Diego, US 26 1032
Ren, Pingda San Deigo, US 183 5844
Wu, Tao Carlsbad, US 353 4184

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 4, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 4, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00